Method for cultivating primary human pulmonary alveolar epithelial cells and application thereof
Disclosed herein is a method for cultivating primary human pulmonary alveolar epithelial cells (HPAEpiC), which includes cultivating the primary HPAEpiC in a first medium containing a basal medium, a culture supplement, and a Rho kinase inhibitor, and a second medium containing the basal medium and the culture supplement in sequence. The culture supplement includes Jagged-1 (JAG-1) peptide, human Noggin protein, transforming growth factor-β (TGF-β) type I receptor inhibitor SB431542, human fibroblast growth factor 7 (hFGF-7), hFGF-10, and glycogen synthase kinase 3 (GSK-3) inhibitor CHIR99021. Also disclosed is a method for preparing a three-dimensional cell culture of alveolar epithelium using the first medium and the second medium.
1. A method for preparing a three-dimensional cell culture of alveolar epithelium, comprising:
subjecting primary human pulmonary alveolar epithelial cells to submerged cultivation in a first medium that includes a basal medium, a culture supplement, and a Rho kinase inhibitor, so as to obtain cultured primary human pulmonary alveolar epithelial cells;
subjecting the cultured primary human pulmonary alveolar epithelial cells to submerged cultivation in a second medium that includes the basal medium and the culture supplement, so as to obtain proliferated primary human pulmonary alveolar epithelial cells; and
subjecting the proliferated primary human pulmonary alveolar epithelial cells to air-liquid interface cultivation in the second medium, so as to obtain the three-dimensional cell culture of alveolar epithelium,
wherein the culture supplement includes Jagged-1 (JAG 1) peptide, human Noggin (hNoggin) protein, SB431542, human fibroblast growth factor 7 (hFGF-7), human fibroblast growth factor 10 (hFGF-10), and CHIR99021.
2. The method as claimed in claim 1 , wherein the primary human pulmonary alveolar epithelial cells are subjected to the submerged cultivation in the first medium in the presence of an extracellular matrix.
3. The method as claimed in claim 2 , wherein the extracellular matrix is selected from the group consisting of type I collagen, type IV collagen, gelatin, fibronectin, solubilized basement membrane matrix secreted by Engelbreth-Holm-Swarm mouse sarcoma cells growth factor reduced (GFR) basement membrane matrix, basement membrane extract, and combinations thereof.